Elliott J. Jenkins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elliott J. Jenkins has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Mike Stembridge
Cardiff School of Sport and Health Sciences Cardiff Metropolitan University Cardiff UK
13 shared publications - Andrew J. M. Douglas
Cardiff School of Sport and Health Sciences Cardiff Metropolitan University Cardiff UK
7 shared publications - Joshua C. Tremblay
Cardiff School of Sport and Health Sciences Cardiff Metropolitan University Cardiff UK
7 shared publications - Joseph A. Killick
Cardiff School of Sport and Health Sciences Cardiff Metropolitan University Cardiff UK
5 shared publications - Liam Corr
Cardiff School of Sport and Health Sciences Cardiff Metropolitan University Cardiff UK
5 shared publications - Philip N. Ainslie
Centre for Heart, Lung and Vascular Health, School of Health and Exercise Sciences University of British Columbia – Okanagan Kelowna British Columbia Canada
5 shared publications
Latest Publications
- 1 November 2026
- Published by Human Kinetics in International Journal of Sport Nutrition and Exercise Metabolism
- Vol. 36 (6) , 622-630
Comparing the Effects of Water, Sodium-Potassium, and Potassium-Rich Solutions on Fluid Balance and Thermal Strain Following Exercise in the Heat: A Randomized Triple-Blind Crossover Study
Exercise in the heat perturbs human physiology through elevated core temperature, fluid loss, and cardiovascular strain. While fluid intake can mitigate these effects, the electrolyte composition of hydration solutions may improve rehydration efficacy. This study evaluated whether hydration strategy modulates thermal strain, inflammation, and performance during and after exercise in a hot environment, comparing three different fluid solutions: water, sodium-potassium drink, and coconut water. Twelve participants (seven males) completed a randomized, triple-blind crossover trial. Measures included handgrip strength, countermovement jump, tympanic temperature, thermal sensation, discomfort, body mass, body water percentage, heart rate, and total leukocyte count. Participants were randomly assigned 300 ml of one of three solutions before cycling for 60 min at 1.5 W/kg in ∼33 °C conditions. Additional 300-ml doses were consumed postexercise at 0, 30, and 60 min; measures were taken at each time point before solution consumption and at 90-min postexercise. Following exercise in the heat, a significant main effect for time was observed for all outcomes: thermal responses, heart rate, body mass and body water ( p < .001); fatigue ( p < .001); and leukocyte count ( p = .016), indicating a strong physiological response to heat stress. However, no significant differences were observed between hydration strategies ( p ≥ .152) for all measures. In conclusion, exercise in the heat elicited significant thermal strain, fatigue, and inflammation, independent of hydration strategy. Electrolyte composition did not significantly alter responses when fluid intake was controlled, highlighting the need for further research.
- 1 November 2026
- Published by Human Kinetics in International Journal of Sport Nutrition and Exercise Metabolism
- Vol. 36 (6) , 622-630
Comparing the Effects of Water, Sodium-Potassium, and Potassium-Rich Solutions on Fluid Balance and Thermal Strain Following Exercise in the Heat: A Randomized Triple-Blind Crossover Study
Exercise in the heat perturbs human physiology through elevated core temperature, fluid loss, and cardiovascular strain. While fluid intake can mitigate these effects, the electrolyte composition of hydration solutions may improve rehydration efficacy. This study evaluated whether hydration strategy modulates thermal strain, inflammation, and performance during and after exercise in a hot environment, comparing three different fluid solutions: water, sodium-potassium drink, and coconut water. Twelve participants (seven males) completed a randomized, triple-blind crossover trial. Measures included handgrip strength, countermovement jump, tympanic temperature, thermal sensation, discomfort, body mass, body water percentage, heart rate, and total leukocyte count. Participants were randomly assigned 300 ml of one of three solutions before cycling for 60 min at 1.5 W/kg in ∼33 °C conditions. Additional 300-ml doses were consumed postexercise at 0, 30, and 60 min; measures were taken at each time point before solution consumption and at 90-min postexercise. Following exercise in the heat, a significant main effect for time was observed for all outcomes: thermal responses, heart rate, body mass and body water ( p < .001); fatigue ( p < .001); and leukocyte count ( p = .016), indicating a strong physiological response to heat stress. However, no significant differences were observed between hydration strategies ( p ≥ .152) for all measures. In conclusion, exercise in the heat elicited significant thermal strain, fatigue, and inflammation, independent of hydration strategy. Electrolyte composition did not significantly alter responses when fluid intake was controlled, highlighting the need for further research.
- Open Access
- 26 October 2026
- Published by Wiley in Experimental Physiology
A 45 min bout of hot‐water immersion induces transient plasma volume contraction without a detectable increase in circulating erythropoietin
Heat acclimation is increasingly used to induce haematological adaptations and enhance endurance performance. Although repeated hot‐water immersion (HWI) has been shown to increase haemoglobin mass, the acute physiological responses that might underpin these longer‐term adaptations remain poorly understood. This study investigated the 24 h time course of plasma volume (PV) and erythropoietin (EPO) responses following a single bout of HWI. Sixteen healthy adults (four females) completed a randomised crossover study comprising 45 min of HWI (40°C) and a time‐matched control condition. Changes in PV were estimated from haemoglobin concentration and haematocrit, while serum EPO concentrations were determined using an ELISA. HWI induced a substantial contraction in PV immediately after immersion (−9.5%, 95% CI [−12.5, −6.5]; P < 0.001), accompanied by marked increases in tympanic temperature and thermal strain. However, PV returned to baseline within 12 h, and no subsequent PV expansion was observed. Serum EPO concentration was unaffected by time ( P = 0.183), condition ( P = 0.125) or the condition × time interaction ( P = 0.309). Furthermore, changes in PV were unrelated to changes in circulating EPO in both the HWI (β = 0.07; [−1.3, 1.4]; P = 0.915) and control (β = 1.10; [−1.1, 3.3]; P = 0.326) conditions. These findings demonstrate that a 45 min bout of HWI induces a substantial but transient contraction in PV that is not accompanied by a measurable increase in circulating EPO within 24 h. Acute PV contractions following HWI therefore appear insufficient to stimulate a measurable erythropoietic response, suggesting that the haematological adaptations observed following chronic heat acclimation may instead depend upon sustained alterations in PV arising from repeated heat exposures.
- 26 October 2026
- Published by Wiley in Experimental Physiology
Open AccessA 45 min bout of hot‐water immersion induces transient plasma volume contraction without a detectable increase in circulating erythropoietin
Heat acclimation is increasingly used to induce haematological adaptations and enhance endurance performance. Although repeated hot‐water immersion (HWI) has been shown to increase haemoglobin mass, the acute physiological responses that might underpin these longer‐term adaptations remain poorly understood. This study investigated the 24 h time course of plasma volume (PV) and erythropoietin (EPO) responses following a single bout of HWI. Sixteen healthy adults (four females) completed a randomised crossover study comprising 45 min of HWI (40°C) and a time‐matched control condition. Changes in PV were estimated from haemoglobin concentration and haematocrit, while serum EPO concentrations were determined using an ELISA. HWI induced a substantial contraction in PV immediately after immersion (−9.5%, 95% CI [−12.5, −6.5]; P < 0.001), accompanied by marked increases in tympanic temperature and thermal strain. However, PV returned to baseline within 12 h, and no subsequent PV expansion was observed. Serum EPO concentration was unaffected by time ( P = 0.183), condition ( P = 0.125) or the condition × time interaction ( P = 0.309). Furthermore, changes in PV were unrelated to changes in circulating EPO in both the HWI (β = 0.07; [−1.3, 1.4]; P = 0.915) and control (β = 1.10; [−1.1, 3.3]; P = 0.326) conditions. These findings demonstrate that a 45 min bout of HWI induces a substantial but transient contraction in PV that is not accompanied by a measurable increase in circulating EPO within 24 h. Acute PV contractions following HWI therefore appear insufficient to stimulate a measurable erythropoietic response, suggesting that the haematological adaptations observed following chronic heat acclimation may instead depend upon sustained alterations in PV arising from repeated heat exposures.
- Open Access
- 31 July 2026
- Published by Wiley in Experimental Physiology
Far‐infrared sauna exposure at 65°C elevates core temperature
Far‐infrared (FIR) saunas are increasingly used as a passive heating and ‘wellness’ modality, yet their capacity to elevate core temperature remains unclear, particularly given prior work at lower temperatures (∼45°C) reports limited net heat storage. We therefore examined whether FIR sauna exposure at an ambient temperature more typical of traditional sauna bathing (65°C) increases core (rectal) temperature and evokes thermoregulatory, cardiovascular, haematological and perceptual responses associated with heat strain. Twelve healthy adults (6 female) completed a single 45‐min FIR sauna exposure. Rectal temperature, skin temperature, heart rate, blood pressure, plasma volume changes and perceptual measures were assessed throughout. Rectal temperature increased by 1.4°C (95% CI: 0.9, 1.8; P < 0.001), with elevations evident from ∼20 min. Skin temperature rose rapidly (+7.4°C [95% CI: 5.4, 9.5] at 5 min; P < 0.001) and remained elevated thereafter. Heart rate increased from 74 ± 15 to 153 ± 20 bpm ( P < 0.001), while mean arterial pressure decreased immediately post‐exposure (−9 mmHg [95% CI: −2, −16]; P = 0.012), driven by reductions in diastolic pressure. Plasma volume contracted by −11.6% (95% CI: −15.9, −7.2; P < 0.001), with a sweat rate of 1.4 ± 0.5 L h − 1 . Thermal sensation and discomfort increased to ‘extremely hot’ and ‘extremely uncomfortable’, respectively ( P < 0.001). In summary, FIR sauna exposure at 65°C elicits substantial increases in rectal temperature and systemic physiological strain comparable to values previously reported in the passive heating literature. These findings indicate that the effectiveness of FIR sauna to increase core temperature is governed by the thermal load imposed, supporting its potential as a heat‐based intervention when applied at sufficiently high temperatures.
- 31 July 2026
- Published by Wiley in Experimental Physiology
Open AccessFar‐infrared sauna exposure at 65°C elevates core temperature
Far‐infrared (FIR) saunas are increasingly used as a passive heating and ‘wellness’ modality, yet their capacity to elevate core temperature remains unclear, particularly given prior work at lower temperatures (∼45°C) reports limited net heat storage. We therefore examined whether FIR sauna exposure at an ambient temperature more typical of traditional sauna bathing (65°C) increases core (rectal) temperature and evokes thermoregulatory, cardiovascular, haematological and perceptual responses associated with heat strain. Twelve healthy adults (6 female) completed a single 45‐min FIR sauna exposure. Rectal temperature, skin temperature, heart rate, blood pressure, plasma volume changes and perceptual measures were assessed throughout. Rectal temperature increased by 1.4°C (95% CI: 0.9, 1.8; P < 0.001), with elevations evident from ∼20 min. Skin temperature rose rapidly (+7.4°C [95% CI: 5.4, 9.5] at 5 min; P < 0.001) and remained elevated thereafter. Heart rate increased from 74 ± 15 to 153 ± 20 bpm ( P < 0.001), while mean arterial pressure decreased immediately post‐exposure (−9 mmHg [95% CI: −2, −16]; P = 0.012), driven by reductions in diastolic pressure. Plasma volume contracted by −11.6% (95% CI: −15.9, −7.2; P < 0.001), with a sweat rate of 1.4 ± 0.5 L h − 1 . Thermal sensation and discomfort increased to ‘extremely hot’ and ‘extremely uncomfortable’, respectively ( P < 0.001). In summary, FIR sauna exposure at 65°C elicits substantial increases in rectal temperature and systemic physiological strain comparable to values previously reported in the passive heating literature. These findings indicate that the effectiveness of FIR sauna to increase core temperature is governed by the thermal load imposed, supporting its potential as a heat‐based intervention when applied at sufficiently high temperatures.
- Open Access
- 19 June 2026
- Published by Wiley in The Journal of Physiology
The role of group III/IV afferent feedback in the ventilatory, pressor and metabolic responses to exercise in normoxia and hypoxia
Group III/IV muscle afferents play a prominent role in ensuring appropriate arterial oxygenation during exercise. Exercise in hypoxia poses a major cardiorespiratory challenge due to reduced inspired oxygen pressure (P I O 2 ). Although humans adapt powerfully to hypoxia, the contribution of group III/IV afferents to ventilatory, pressor and metabolic responses to exercise in chronic hypoxia remains unknown. Fourteen healthy participants completed cycling trials with (placebo) and without (25 µg intrathecal fentanyl) intact group III/IV afferent feedback in three settings: (1) normoxia, P I O 2 = 139 mmHg; (2) acute hypoxia, P I O 2 = 90 mmHg; and (3) chronic hypoxia, after 7–9 days of acclimatisation to 3800 m, P I O 2 = 90 mmHg. Participants completed three 3‐min stages at matched absolute intensities corresponding to 45%, 60% and 75% sea‐level maximal aerobic power. Ventilation, pulmonary gas exchange, arterial blood gases and blood pressure were measured. Fentanyl suppressed exercise hyperpnoea similarly across environments ( P < 0.001) but produced larger reductions in arterial oxygenation in hypoxia, lowering saturation by ∼3%–5% and content by ∼0.7–1.0 ml dL −1 ( condition×P I O 2 , P ≤ 0.016). Fentanyl also blunted the exercise‐induced increase in mean arterial pressure, with a greater blood pressure–lowering effect of –10 to 13 mmHg observed in hypoxia ( condition×P I O 2 , P = 0.021). In contrast fentanyl increased circulating lactate and hydrogen ion concentration ([H + ]) ( P < 0.001), an effect accentuated during acute hypoxia (lactate: +1–2 mmol L − 1 , [H + ]: +2–5 nmol L − 1 ) but attenuated after acclimatisation ( interactions , P ≤ 0.034). Thus group III/IV afferent feedback becomes more consequential in hypoxia, as small perturbations in ventilatory control and perfusion pressure have amplified consequences for oxygen transport. image Key points: Group III/IV muscle afferent feedback contributes to normal exercise hyperpnoea and blood pressure regulation; whether its functional contribution is altered by acute and chronic hypoxia is unknown. In a double‐blind, placebo‐controlled cross‐over design, 14 participants completed steady‐state cycling with intact (placebo) or attenuated (intrathecal fentanyl) group III/IV afferent feedback in normoxia, acute hypoxia and after 7–9 days of acclimatisation at 3800 m. Intrathecal fentanyl suppressed exercise hyperpnoea similarly across environments but caused exaggerated arterial oxygen desaturation during hypoxic exercise, reflecting operation on the steep portion of the oxygen–haemoglobin dissociation curve. The blood pressure–lowering effect of intrathecal fentanyl was greater during hypoxic exercise; effects on metabolic strain were greatest in acute hypoxia and largely normalised after acclimatisation. These findings highlight the functional importance of group III/IV muscle afferent feedback during hypoxic exercise, where small perturbations in ventilatory and pressor control have amplified consequences for oxygen transport.
- 19 June 2026
- Published by Wiley in The Journal of Physiology
Open AccessThe role of group III/IV afferent feedback in the ventilatory, pressor and metabolic responses to exercise in normoxia and hypoxia
Group III/IV muscle afferents play a prominent role in ensuring appropriate arterial oxygenation during exercise. Exercise in hypoxia poses a major cardiorespiratory challenge due to reduced inspired oxygen pressure (P I O 2 ). Although humans adapt powerfully to hypoxia, the contribution of group III/IV afferents to ventilatory, pressor and metabolic responses to exercise in chronic hypoxia remains unknown. Fourteen healthy participants completed cycling trials with (placebo) and without (25 µg intrathecal fentanyl) intact group III/IV afferent feedback in three settings: (1) normoxia, P I O 2 = 139 mmHg; (2) acute hypoxia, P I O 2 = 90 mmHg; and (3) chronic hypoxia, after 7–9 days of acclimatisation to 3800 m, P I O 2 = 90 mmHg. Participants completed three 3‐min stages at matched absolute intensities corresponding to 45%, 60% and 75% sea‐level maximal aerobic power. Ventilation, pulmonary gas exchange, arterial blood gases and blood pressure were measured. Fentanyl suppressed exercise hyperpnoea similarly across environments ( P < 0.001) but produced larger reductions in arterial oxygenation in hypoxia, lowering saturation by ∼3%–5% and content by ∼0.7–1.0 ml dL −1 ( condition×P I O 2 , P ≤ 0.016). Fentanyl also blunted the exercise‐induced increase in mean arterial pressure, with a greater blood pressure–lowering effect of –10 to 13 mmHg observed in hypoxia ( condition×P I O 2 , P = 0.021). In contrast fentanyl increased circulating lactate and hydrogen ion concentration ([H + ]) ( P < 0.001), an effect accentuated during acute hypoxia (lactate: +1–2 mmol L − 1 , [H + ]: +2–5 nmol L − 1 ) but attenuated after acclimatisation ( interactions , P ≤ 0.034). Thus group III/IV afferent feedback becomes more consequential in hypoxia, as small perturbations in ventilatory control and perfusion pressure have amplified consequences for oxygen transport. image Key points: Group III/IV muscle afferent feedback contributes to normal exercise hyperpnoea and blood pressure regulation; whether its functional contribution is altered by acute and chronic hypoxia is unknown. In a double‐blind, placebo‐controlled cross‐over design, 14 participants completed steady‐state cycling with intact (placebo) or attenuated (intrathecal fentanyl) group III/IV afferent feedback in normoxia, acute hypoxia and after 7–9 days of acclimatisation at 3800 m. Intrathecal fentanyl suppressed exercise hyperpnoea similarly across environments but caused exaggerated arterial oxygen desaturation during hypoxic exercise, reflecting operation on the steep portion of the oxygen–haemoglobin dissociation curve. The blood pressure–lowering effect of intrathecal fentanyl was greater during hypoxic exercise; effects on metabolic strain were greatest in acute hypoxia and largely normalised after acclimatisation. These findings highlight the functional importance of group III/IV muscle afferent feedback during hypoxic exercise, where small perturbations in ventilatory and pressor control have amplified consequences for oxygen transport.
- Open Access
- 18 June 2026
- Published by Wiley in The Journal of Physiology
Mechanisms reducing parasympathetic activity in chronic hypoxia
Parasympathetic activity is reduced in chronic hypoxia, but the underlying mechanism(s) are unclear. We investigated whether (i) arterial chemoreflex activation, (ii) increased pulmonary ventilation and/or (iii) pulmonary stretch, (iv) hypocapnia resulting from increased ventilation or (v) hypovolemia due to plasma volume contraction reduce parasympathetic activity in chronic hypoxia. In 13 lowlanders (8M/5F), we administered β‐adrenergic blockade (intravenous propranolol) to isolate parasympathetic control of HR and thus use HR as a reciprocal index of parasympathetic activity, first at sea level (SL) and then after 9–12 days of exposure to high altitude (HA, 3800 m). Under β‐adrenergic blockade, HR was 9.3 ± 6.5bpm higher at HA than at SL ( P < 0.001), supporting parasympathetic withdrawal in chronic hypoxia. This HA‐induced HR increase remained unchanged when (i) the arterial chemoreflex was inhibited by pure oxygen breathing ( P = 0.083) but decreased when (ii) pulmonary ventilation was matched between SL and HA by paced breathing ( P = 0.031). Performing apnoeas abolishing differences in pulmonary stretch (iii) did not reduce the HA‐induced HR acceleration ( P = 0.275), whereas (iv) increasing end‐tidal CO 2 partial pressure to counteract hypocapnia at HA further enhanced it ( P = 0.006). Restoring blood volume at HA to SL values by saline infusion (v) also failed to reduce the HA‐induced HR acceleration ( P = 0.813). Our findings support a contribution of increased ventilation, but not of arterial chemoreflex activation, hypocapnia or hypovolemia, to the parasympathetic withdrawal associated with chronic hypoxia. That performing apnoea failed to reduce the HA‐induced elevation in HR furthermore indicates that the increased ventilation reduces parasympathetic activity via mechanisms other than pulmonary stretch. image Key points: Chronic hypoxia reduces parasympathetic activity, but the underlying mechanisms remain unclear. At sea level and after 9–12 days of sojourn at high altitude, we used β‐adrenergic blockade to isolate parasympathetic control of the heart, so that heart rate could be used as a reciprocal index for parasympathetic activity. Heart rate under β‐adrenergic blockade was higher at high altitude than at sea level, supporting parasympathetic withdrawal in chronic hypoxia. Matching ventilation between sea level and high altitude reduced the high altitude‐induced heart rate acceleration, indicating that the increased pulmonary ventilation in chronic hypoxia contributes to parasympathetic withdrawal. Conversely, the high altitude‐induced heart rate acceleration was not reduced by inhibition of the arterial chemoreflex, or removal of hypoxia‐indued hypocapnia or hypovolemia, thus not supporting these as mechanisms of reduced parasympathetic activity in chronic hypoxia.
- 18 June 2026
- Published by Wiley in The Journal of Physiology
Open AccessMechanisms reducing parasympathetic activity in chronic hypoxia
Parasympathetic activity is reduced in chronic hypoxia, but the underlying mechanism(s) are unclear. We investigated whether (i) arterial chemoreflex activation, (ii) increased pulmonary ventilation and/or (iii) pulmonary stretch, (iv) hypocapnia resulting from increased ventilation or (v) hypovolemia due to plasma volume contraction reduce parasympathetic activity in chronic hypoxia. In 13 lowlanders (8M/5F), we administered β‐adrenergic blockade (intravenous propranolol) to isolate parasympathetic control of HR and thus use HR as a reciprocal index of parasympathetic activity, first at sea level (SL) and then after 9–12 days of exposure to high altitude (HA, 3800 m). Under β‐adrenergic blockade, HR was 9.3 ± 6.5bpm higher at HA than at SL ( P < 0.001), supporting parasympathetic withdrawal in chronic hypoxia. This HA‐induced HR increase remained unchanged when (i) the arterial chemoreflex was inhibited by pure oxygen breathing ( P = 0.083) but decreased when (ii) pulmonary ventilation was matched between SL and HA by paced breathing ( P = 0.031). Performing apnoeas abolishing differences in pulmonary stretch (iii) did not reduce the HA‐induced HR acceleration ( P = 0.275), whereas (iv) increasing end‐tidal CO 2 partial pressure to counteract hypocapnia at HA further enhanced it ( P = 0.006). Restoring blood volume at HA to SL values by saline infusion (v) also failed to reduce the HA‐induced HR acceleration ( P = 0.813). Our findings support a contribution of increased ventilation, but not of arterial chemoreflex activation, hypocapnia or hypovolemia, to the parasympathetic withdrawal associated with chronic hypoxia. That performing apnoea failed to reduce the HA‐induced elevation in HR furthermore indicates that the increased ventilation reduces parasympathetic activity via mechanisms other than pulmonary stretch. image Key points: Chronic hypoxia reduces parasympathetic activity, but the underlying mechanisms remain unclear. At sea level and after 9–12 days of sojourn at high altitude, we used β‐adrenergic blockade to isolate parasympathetic control of the heart, so that heart rate could be used as a reciprocal index for parasympathetic activity. Heart rate under β‐adrenergic blockade was higher at high altitude than at sea level, supporting parasympathetic withdrawal in chronic hypoxia. Matching ventilation between sea level and high altitude reduced the high altitude‐induced heart rate acceleration, indicating that the increased pulmonary ventilation in chronic hypoxia contributes to parasympathetic withdrawal. Conversely, the high altitude‐induced heart rate acceleration was not reduced by inhibition of the arterial chemoreflex, or removal of hypoxia‐indued hypocapnia or hypovolemia, thus not supporting these as mechanisms of reduced parasympathetic activity in chronic hypoxia.
- Open Access
- 17 June 2026
- Published by Wiley in The Journal of Physiology
The influence of metaboreflex activation on pulmonary pressure with combined chemoreflex activation in acute and chronic hypoxia
Sympathetic activation arising from both the peripheral chemoreflex in hypoxia and muscle metaboreflex during exercise mediate an increase in pulmonary artery systolic pressure (PASP). We tested the hypothesis that coactivation of the chemoreflex and metaboreflex would augment the PASP response, as has been shown previously for heart rate and ventilation. We conducted two experimental studies: (i) a laboratory study ( n = 15) in normoxia and acute isocapnic hypoxia (45 mmHg ) and (ii) a field study ( n = 14) at sea level (344 m) and after 4–6 days of acclimatisation to high altitude (3800 m). In both studies, participants performed 3 min of isometric handgrip at 30% of maximal voluntary contraction followed by 3 min of post‐exercise circulatory occlusion (PECO). PASP was assessed via transthoracic echocardiography. In Study 1, isocapnic hypoxia reduced (44.3 ± 5.3 mHg; P < 0.001) but maintained (36.8 ± 2.3; P = 0.931) compared to normoxia. Both PECO (+5.3 ± 5.3 mmHg; P = 0.044) and hypoxia (+4.0 ± 2.0 mmHg; P = 0.016) elevated PASP from baseline, whereas combined hypoxic PECO further increased PASP (+8.4 ± 3.7 mmHg, P = 0.009). These responses were unaltered following acclimatisation to 3800 m in Study 2. Importantly, irrespective of the duration of hypoxic exposure and thus the degree of carotid body stimulation, the sum of the individual responses to hypoxia and PECO was not different compared to the combined hypoxic PECO stimulus in either acute ( P = 0.806) or chronic hypoxia ( P = 0.896). Therefore, although both chemoreflex activation with hypoxia and metaboreflex activation with PECO increase PASP, their coactivation results in an additive, not synergistic, response. image Key points: Activation of the peripheral chemoreflex (e.g. hypoxia) and muscle metaboreflex (e.g. exercise) both increase heart rate, arterial pressure, ventilation and pulmonary pressure. There is evidence of an augmented muscle metaboreflex response for heart rate and ventilation in acute hypoxia, but whether the same effect is seen in the pulmonary vasculature has not been explored. We completed two experimental studies where pulmonary artery systolic pressure (PASP) was assessed during post‐exercise circulatory occlusion (PECO) in response to acute isocapnic hypoxia and following acclimatisation to high altitude hypoxia (3800 m). Independent activation of the chemoreflex at rest and metaboreflex during PECO elevated PASP in both acute and chronic hypoxia. When combined, metaboreflex activation with PECO and chemoreflex activation with hypoxia have an additive but not interactive effect on PASP, irrespective of the duration of hypoxic exposure.
- 17 June 2026
- Published by Wiley in The Journal of Physiology
Open AccessThe influence of metaboreflex activation on pulmonary pressure with combined chemoreflex activation in acute and chronic hypoxia
Sympathetic activation arising from both the peripheral chemoreflex in hypoxia and muscle metaboreflex during exercise mediate an increase in pulmonary artery systolic pressure (PASP). We tested the hypothesis that coactivation of the chemoreflex and metaboreflex would augment the PASP response, as has been shown previously for heart rate and ventilation. We conducted two experimental studies: (i) a laboratory study ( n = 15) in normoxia and acute isocapnic hypoxia (45 mmHg ) and (ii) a field study ( n = 14) at sea level (344 m) and after 4–6 days of acclimatisation to high altitude (3800 m). In both studies, participants performed 3 min of isometric handgrip at 30% of maximal voluntary contraction followed by 3 min of post‐exercise circulatory occlusion (PECO). PASP was assessed via transthoracic echocardiography. In Study 1, isocapnic hypoxia reduced (44.3 ± 5.3 mHg; P < 0.001) but maintained (36.8 ± 2.3; P = 0.931) compared to normoxia. Both PECO (+5.3 ± 5.3 mmHg; P = 0.044) and hypoxia (+4.0 ± 2.0 mmHg; P = 0.016) elevated PASP from baseline, whereas combined hypoxic PECO further increased PASP (+8.4 ± 3.7 mmHg, P = 0.009). These responses were unaltered following acclimatisation to 3800 m in Study 2. Importantly, irrespective of the duration of hypoxic exposure and thus the degree of carotid body stimulation, the sum of the individual responses to hypoxia and PECO was not different compared to the combined hypoxic PECO stimulus in either acute ( P = 0.806) or chronic hypoxia ( P = 0.896). Therefore, although both chemoreflex activation with hypoxia and metaboreflex activation with PECO increase PASP, their coactivation results in an additive, not synergistic, response. image Key points: Activation of the peripheral chemoreflex (e.g. hypoxia) and muscle metaboreflex (e.g. exercise) both increase heart rate, arterial pressure, ventilation and pulmonary pressure. There is evidence of an augmented muscle metaboreflex response for heart rate and ventilation in acute hypoxia, but whether the same effect is seen in the pulmonary vasculature has not been explored. We completed two experimental studies where pulmonary artery systolic pressure (PASP) was assessed during post‐exercise circulatory occlusion (PECO) in response to acute isocapnic hypoxia and following acclimatisation to high altitude hypoxia (3800 m). Independent activation of the chemoreflex at rest and metaboreflex during PECO elevated PASP in both acute and chronic hypoxia. When combined, metaboreflex activation with PECO and chemoreflex activation with hypoxia have an additive but not interactive effect on PASP, irrespective of the duration of hypoxic exposure.
- Open Access
- 7 May 2026
- Published by Wiley in Experimental Physiology
Daily hot‐water immersion preserves altitude‐induced haemoglobin mass expansion following descent independent of erythropoietin
High‐altitude exposure increases haemoglobin mass (Hb mass ), a key determinant of arterial oxygen‐carrying capacity, but following descent this adaptation can regress toward baseline within 7 days. Long‐term heat acclimation has emerged as an alternative stimulus for Hb mass expansion; however, whether post‐altitude passive‐heat exposure can preserve altitude‐induced increases in Hb mass remains unclear. Furthermore, the extent to which any preservation of Hb mass is supported by sustained erythropoietin (EPO) production, and whether this support is mediated by plasma volume expansion or acute alterations in renal haemodynamics, has yet to be explored. Twenty‐one healthy adults (8F) sojourned at 3800 m for 14 days and, following descent to 1250 m, were allocated to either hot‐water immersion (HWI; 45 min at 40°C for 4 days; n = 11) or control (CON; n = 10). Hb mass , intravascular volumes (carbon monoxide rebreathing) and circulating EPO were measured on high‐altitude day 1 (HA1), day 14 (HA14), and post‐descent day 5 (P5). Renal‐artery blood velocity (Doppler‐ultrasound) was measured before and after HWI on the day of descent. Hb mass increased by 24 g [95% CI: 8, 40] across all participants during the altitude sojourn ( P = 0.005). Following descent, Hb mass decreased in CON (∆ = −18 g [95% CI: −36, 0], P = 0.045) but was maintained in HWI (∆ = +9 g [95% CI: −8, 26], P = 0.285). Circulating EPO declined after descent ( P < 0.001) with no between‐condition difference at P5 ( P = 0.239), despite a transient reduction in renal‐artery blood velocity following HWI ( P = 0.025) and similar plasma volume expansion across groups (time: P < 0.001). Hot‐water immersion offers a practical, lower‐impact alternative to exercise‐heat methods for preserving altitude‐derived Hb mass expansion, although the mechanisms underlying this response remain elusive.
- 7 May 2026
- Published by Wiley in Experimental Physiology
Open AccessDaily hot‐water immersion preserves altitude‐induced haemoglobin mass expansion following descent independent of erythropoietin
High‐altitude exposure increases haemoglobin mass (Hb mass ), a key determinant of arterial oxygen‐carrying capacity, but following descent this adaptation can regress toward baseline within 7 days. Long‐term heat acclimation has emerged as an alternative stimulus for Hb mass expansion; however, whether post‐altitude passive‐heat exposure can preserve altitude‐induced increases in Hb mass remains unclear. Furthermore, the extent to which any preservation of Hb mass is supported by sustained erythropoietin (EPO) production, and whether this support is mediated by plasma volume expansion or acute alterations in renal haemodynamics, has yet to be explored. Twenty‐one healthy adults (8F) sojourned at 3800 m for 14 days and, following descent to 1250 m, were allocated to either hot‐water immersion (HWI; 45 min at 40°C for 4 days; n = 11) or control (CON; n = 10). Hb mass , intravascular volumes (carbon monoxide rebreathing) and circulating EPO were measured on high‐altitude day 1 (HA1), day 14 (HA14), and post‐descent day 5 (P5). Renal‐artery blood velocity (Doppler‐ultrasound) was measured before and after HWI on the day of descent. Hb mass increased by 24 g [95% CI: 8, 40] across all participants during the altitude sojourn ( P = 0.005). Following descent, Hb mass decreased in CON (∆ = −18 g [95% CI: −36, 0], P = 0.045) but was maintained in HWI (∆ = +9 g [95% CI: −8, 26], P = 0.285). Circulating EPO declined after descent ( P < 0.001) with no between‐condition difference at P5 ( P = 0.239), despite a transient reduction in renal‐artery blood velocity following HWI ( P = 0.025) and similar plasma volume expansion across groups (time: P < 0.001). Hot‐water immersion offers a practical, lower‐impact alternative to exercise‐heat methods for preserving altitude‐derived Hb mass expansion, although the mechanisms underlying this response remain elusive.
- Open Access
- 8 April 2026
- Published by Wiley in The Journal of Physiology
Maximal exercise at high altitude does not exacerbate inflammation in the human brain
How neuroinflammation is altered at high altitude (HA) is equivocal, and it is unclear whether and how exercise alters this inflammatory response. We tested the hypothesis that maximal exercise at HA exacerbates the neuroinflammatory response. Healthy adults ( n = 12, 6/6 females/males) completed 60 min of steady‐state semi‐recumbent low‐intensity cycling exercise and an incremental maximal test at sea level (SL) and following 6–8 days at 3800 m a.s.l. (HA). Radial arterial and internal jugular venous (IJV) sampling and duplex volumetric blood flow of the internal carotid and vertebral arteries was used to assess trans‐cerebral exchange of cytokines at rest and 5 min after maximal exercise (POST‐MAX‐5). Arterial–IJV uptake/release of cytokines at rest was not different between altitudes. Arterial leucocytes were increased by 57%–66% at POST‐MAX‐5 at both SL ( P < 0.001) and HA ( P < 0.001); exercise × altitude, P = 0.433, with no difference between arterial and IJV. Apart from a trivial absolute increase in arterial interleukin‐6 at HA (Δ +0.62 pg ml −1 , 95% confidence interval [0.10, 1.15], P = 0.022), the remaining 16 of the 17 measured systemic cytokines were unaffected by maximal exercise at both altitudes ( P > 0.05). There was a shift towards trans‐cerebral net release by −1.3 to −8.2 pg ml −1 ( P < 0.05) of interleukin‐6, interleukin‐8, monocyte chemoattractant protein‐1 and macrophage inflammatory protein‐1 beta at POST‐MAX‐5 at both altitudes. The release of these cytokines occurred independently of systemic inflammation and altitude exposure. The results of this study indicate that partial acclimatization at 3800 m a.s.l. does not alter the physiological release of cytokines from the brain in response to maximal exercise. image Key points: Systemic inflammation is altered at high altitude, but it is unclear how exercise at altitude affects inflammation in the brain. We tested the hypothesis that maximal exercise will augment the cerebrovascular inflammatory response at high altitude. Exposure to 6–8 days at high altitude did not evoke systemic or brain inflammation at rest and did not exacerbate responses to maximal exercise. There was a shift towards net release of interleukin‐6, interleukin‐8, monocyte chemoattractant protein‐1 and macrophage inflammatory protein‐1 beta following maximal exercise at both altitudes, driven by an increase in internal jugular venous concentration. These new results show that the adaptive physiological response to exercise involves net release of select cytokines from the brain; this occurred in the absence of systemic inflammation and irrespective of high altitude.
- 8 April 2026
- Published by Wiley in The Journal of Physiology
Open AccessMaximal exercise at high altitude does not exacerbate inflammation in the human brain
How neuroinflammation is altered at high altitude (HA) is equivocal, and it is unclear whether and how exercise alters this inflammatory response. We tested the hypothesis that maximal exercise at HA exacerbates the neuroinflammatory response. Healthy adults ( n = 12, 6/6 females/males) completed 60 min of steady‐state semi‐recumbent low‐intensity cycling exercise and an incremental maximal test at sea level (SL) and following 6–8 days at 3800 m a.s.l. (HA). Radial arterial and internal jugular venous (IJV) sampling and duplex volumetric blood flow of the internal carotid and vertebral arteries was used to assess trans‐cerebral exchange of cytokines at rest and 5 min after maximal exercise (POST‐MAX‐5). Arterial–IJV uptake/release of cytokines at rest was not different between altitudes. Arterial leucocytes were increased by 57%–66% at POST‐MAX‐5 at both SL ( P < 0.001) and HA ( P < 0.001); exercise × altitude, P = 0.433, with no difference between arterial and IJV. Apart from a trivial absolute increase in arterial interleukin‐6 at HA (Δ +0.62 pg ml −1 , 95% confidence interval [0.10, 1.15], P = 0.022), the remaining 16 of the 17 measured systemic cytokines were unaffected by maximal exercise at both altitudes ( P > 0.05). There was a shift towards trans‐cerebral net release by −1.3 to −8.2 pg ml −1 ( P < 0.05) of interleukin‐6, interleukin‐8, monocyte chemoattractant protein‐1 and macrophage inflammatory protein‐1 beta at POST‐MAX‐5 at both altitudes. The release of these cytokines occurred independently of systemic inflammation and altitude exposure. The results of this study indicate that partial acclimatization at 3800 m a.s.l. does not alter the physiological release of cytokines from the brain in response to maximal exercise. image Key points: Systemic inflammation is altered at high altitude, but it is unclear how exercise at altitude affects inflammation in the brain. We tested the hypothesis that maximal exercise will augment the cerebrovascular inflammatory response at high altitude. Exposure to 6–8 days at high altitude did not evoke systemic or brain inflammation at rest and did not exacerbate responses to maximal exercise. There was a shift towards net release of interleukin‐6, interleukin‐8, monocyte chemoattractant protein‐1 and macrophage inflammatory protein‐1 beta following maximal exercise at both altitudes, driven by an increase in internal jugular venous concentration. These new results show that the adaptive physiological response to exercise involves net release of select cytokines from the brain; this occurred in the absence of systemic inflammation and irrespective of high altitude.
- Open Access
- 2 February 2026
- Published by Wiley in Experimental Physiology
Influence of facial cooling on carotid body tonic activity and sensitivity
Facial cooling can increase ventilation and augment the hypoxic ventilatory response. Whole body cooling increases both carotid body tonic activity and sensitivity; however, whether isolated facial cooling induces similar carotid body hyperexcitability was unknown. We investigated whether facial cooling alters carotid body function by assessing tonic activity and hypoxic sensitivity. Fourteen healthy adults (11 M/3 F; age 26 ± 4 years) completed a counterbalanced, crossover study involving transient hyperoxia and poikilocapnic hypoxia (9.5% O 2 ) under thermoneutral (facial temperature: 34.2 ± 1.2°C) and facial cooling (19.4 ± 3.3°C) conditions. Carotid body tonic activity was inferred from the ventilatory suppression during transient hyperoxia. Sensitivity was assessed via the change in end‐tidal CO 2 () relative to oxygen saturation () during hypoxia. Facial cooling induced hyperventilation, evidenced by reduced (35 ± 8 vs. 41 ± 3 mmHg; P = 0.008), and elevated ventilatory equivalent for CO 2 production (28 ± 6 vs. 23 ± 2; P = 0.02). Carotid body tonic activity did not differ between facial cooling and thermoneutral conditions, but carotid body sensitivity was reduced during facial cooling (0.20 ± 0.14 vs. 0.28 ± 0.13 mmHg/%; P = 0.044). The reduction in experienced during facial cooling correlated with enhanced carotid body tonic activity ( R 2 = 0.39, P = 0.022) and reduced sensitivity ( R 2 = 0.33, P = 0.03). Collectively, facial cooling induces hyperventilation and the attendant hypocapnia reduces carotid body sensitivity. Although this hyperventilation is related to carotid body tonic activity, facial cooling likely produces a cold shock response that stimulates ventilation separately from the carotid body. These findings offer new insights on the interaction between stimuli relevant to outdoor activities in cold environments (e.g., snow shovelling, mountaineering, cold water swimming) and carotid body function.
- 2 February 2026
- Published by Wiley in Experimental Physiology
Open AccessInfluence of facial cooling on carotid body tonic activity and sensitivity
Facial cooling can increase ventilation and augment the hypoxic ventilatory response. Whole body cooling increases both carotid body tonic activity and sensitivity; however, whether isolated facial cooling induces similar carotid body hyperexcitability was unknown. We investigated whether facial cooling alters carotid body function by assessing tonic activity and hypoxic sensitivity. Fourteen healthy adults (11 M/3 F; age 26 ± 4 years) completed a counterbalanced, crossover study involving transient hyperoxia and poikilocapnic hypoxia (9.5% O 2 ) under thermoneutral (facial temperature: 34.2 ± 1.2°C) and facial cooling (19.4 ± 3.3°C) conditions. Carotid body tonic activity was inferred from the ventilatory suppression during transient hyperoxia. Sensitivity was assessed via the change in end‐tidal CO 2 () relative to oxygen saturation () during hypoxia. Facial cooling induced hyperventilation, evidenced by reduced (35 ± 8 vs. 41 ± 3 mmHg; P = 0.008), and elevated ventilatory equivalent for CO 2 production (28 ± 6 vs. 23 ± 2; P = 0.02). Carotid body tonic activity did not differ between facial cooling and thermoneutral conditions, but carotid body sensitivity was reduced during facial cooling (0.20 ± 0.14 vs. 0.28 ± 0.13 mmHg/%; P = 0.044). The reduction in experienced during facial cooling correlated with enhanced carotid body tonic activity ( R 2 = 0.39, P = 0.022) and reduced sensitivity ( R 2 = 0.33, P = 0.03). Collectively, facial cooling induces hyperventilation and the attendant hypocapnia reduces carotid body sensitivity. Although this hyperventilation is related to carotid body tonic activity, facial cooling likely produces a cold shock response that stimulates ventilation separately from the carotid body. These findings offer new insights on the interaction between stimuli relevant to outdoor activities in cold environments (e.g., snow shovelling, mountaineering, cold water swimming) and carotid body function.
- Open Access
- 14 December 2025
- Published by Wiley in The Journal of Physiology
Role of reactive oxygen species in mediating peripheral hypoxic vasodilation and sympathoexcitation at high altitude
High‐altitude acclimatisation increases muscle sympathetic nerve activity (MSNA) via activation of the arterial chemoreflex, pulmonary arterial baroreceptors and resetting of the sympathetic vascular baroreflex. However attempting to silence these mechanisms only partially normalises MSNA, implicating other contributory mechanisms. Increased oxidant production may modulate central sympathetic outflow, while potentially modifying chemosensitivity and vasomotor signalling to the peripheral and pulmonary vasculature. Therefore we tested the hypothesis that blunting oxidative stress would reduce MSNA at high altitude. MSNA (microneurography of the peroneal nerve), continuous arterial pressure (photoplethysmography), vascular tone (duplex ultrasound of the brachial artery), pulmonary artery systolic pressure (PASP, echocardiography) and carotid body tonic activity (1‐min hyperoxia) were measured pre‐ and post‐ascorbic acid infusion (200 mg/min for 15‐min and then 40 mg/min) in healthy lowlanders ( n = 15) after 3–7 days of high‐altitude exposure (3800 m). Ascorbic acid infusion improved the redox environment, determined by an increase in whole cell nuclear factor erythroid 2‐related factor 2 activity ( P = 0.005). Post‐infusion MSNA burst frequency (−2 ± 2 bursts/min, P = 0.007) and incidence (−5 ± 4 bursts/100 heartbeats (HB), P = 0.006) decreased. However the infusion increased mean arterial (9 ± 4 mmHg, P ≤0.001), systolic (11 ± 8 mmHg, P ≤ 0.004) and diastolic pressure (7 ± 4 mmHg, P ≤ 0.001) and total peripheral resistance ( P = 0.013) concomitantly with a reduction in brachial diameter (−0.12 ± 0.14 mm, P = 0.002). Carotid body tonic activity ( P = 0.247) and PASP ( P = 0.365) remained unchanged by ascorbic acid infusion. In conclusion improving the antioxidant environment lowered MSNA at high altitude; however the small reduction is likely a consequence of the increased blood pressure secondary to the blunting of hypoxic vasodilation rather than a direct effect on sympathetic outflow. image Key points: High‐altitude acclimatisation increases muscle sympathetic nerve activity (MSNA) from sea level values. Pulmonary artery systolic pressure (PASP), peripheral arterial chemoreflex and high altitude‐induced hypovolaemia are involved in the increase in MSNA; however current evidence indicates additional contributory mechanisms. Hypoxia associated with high altitude results in an increase in the production of reactive oxygen species (ROS), which may be sympathoexcitatory. Therefore we tested the hypothesis that improving the redox environment using an ascorbic acid infusion would lower sympathetic nerve activity. After the infusion, sympathetic nerve activity was reduced alongside an increase in vascular tone and elevation in blood pressure. The reduction in MSNA occurred independently of changes in PASP and chemoreflex activity. Our findings demonstrate that ROS elevates sympathetic nerve activity at high altitude; however this reduction is likely a result of the elevated blood pressure after the blunting of hypoxic vasodilation.
- 14 December 2025
- Published by Wiley in The Journal of Physiology
Open AccessRole of reactive oxygen species in mediating peripheral hypoxic vasodilation and sympathoexcitation at high altitude
High‐altitude acclimatisation increases muscle sympathetic nerve activity (MSNA) via activation of the arterial chemoreflex, pulmonary arterial baroreceptors and resetting of the sympathetic vascular baroreflex. However attempting to silence these mechanisms only partially normalises MSNA, implicating other contributory mechanisms. Increased oxidant production may modulate central sympathetic outflow, while potentially modifying chemosensitivity and vasomotor signalling to the peripheral and pulmonary vasculature. Therefore we tested the hypothesis that blunting oxidative stress would reduce MSNA at high altitude. MSNA (microneurography of the peroneal nerve), continuous arterial pressure (photoplethysmography), vascular tone (duplex ultrasound of the brachial artery), pulmonary artery systolic pressure (PASP, echocardiography) and carotid body tonic activity (1‐min hyperoxia) were measured pre‐ and post‐ascorbic acid infusion (200 mg/min for 15‐min and then 40 mg/min) in healthy lowlanders ( n = 15) after 3–7 days of high‐altitude exposure (3800 m). Ascorbic acid infusion improved the redox environment, determined by an increase in whole cell nuclear factor erythroid 2‐related factor 2 activity ( P = 0.005). Post‐infusion MSNA burst frequency (−2 ± 2 bursts/min, P = 0.007) and incidence (−5 ± 4 bursts/100 heartbeats (HB), P = 0.006) decreased. However the infusion increased mean arterial (9 ± 4 mmHg, P ≤0.001), systolic (11 ± 8 mmHg, P ≤ 0.004) and diastolic pressure (7 ± 4 mmHg, P ≤ 0.001) and total peripheral resistance ( P = 0.013) concomitantly with a reduction in brachial diameter (−0.12 ± 0.14 mm, P = 0.002). Carotid body tonic activity ( P = 0.247) and PASP ( P = 0.365) remained unchanged by ascorbic acid infusion. In conclusion improving the antioxidant environment lowered MSNA at high altitude; however the small reduction is likely a consequence of the increased blood pressure secondary to the blunting of hypoxic vasodilation rather than a direct effect on sympathetic outflow. image Key points: High‐altitude acclimatisation increases muscle sympathetic nerve activity (MSNA) from sea level values. Pulmonary artery systolic pressure (PASP), peripheral arterial chemoreflex and high altitude‐induced hypovolaemia are involved in the increase in MSNA; however current evidence indicates additional contributory mechanisms. Hypoxia associated with high altitude results in an increase in the production of reactive oxygen species (ROS), which may be sympathoexcitatory. Therefore we tested the hypothesis that improving the redox environment using an ascorbic acid infusion would lower sympathetic nerve activity. After the infusion, sympathetic nerve activity was reduced alongside an increase in vascular tone and elevation in blood pressure. The reduction in MSNA occurred independently of changes in PASP and chemoreflex activity. Our findings demonstrate that ROS elevates sympathetic nerve activity at high altitude; however this reduction is likely a result of the elevated blood pressure after the blunting of hypoxic vasodilation.